LexDanaLexDanabeta
Inventor

III, William John DRURY

Inventor
US

Overview

3→
Patents
2023–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C12NMicroorganisms or enzymes25%
C07HSugars17%
C07KPeptides8%
PatentTitleYear
12,595,482Linkage modified oligomeric compounds and uses thereof202612,115,225GLP-1 receptor ligand moiety conjugated oligonucleotides and uses thereof202411,629,348Linkage modified oligomeric compounds and uses thereof2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2026Patents assigned to IONIS PHARMACEUTICALS INC (3)· patent assignee history
2023–2026Based in US· patent location history
2024Patents assigned to ASTRAZENECA AB (1)· patent assignee history
2024Based in SE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
IONIS PHARMACEUTICALS INC32023–2026
ASTRAZENECA AB12024
Locations
LocationPatentsSpan
US22023–2026
SE12024